Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
NEXIEN BIOPHARMA, INC. (NXEN) had Non-Operating Income/Expense of $-0.08M for the most recently reported fiscal year, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
$-0.24M |
|
-- |
|
-- |
|
$0.16M |
|
$-0.16M |
|
|
Non-Operating Income/Expense |
$-0.08M |
$-0.24M |
|
$-0.24M |
|
$-0.24M |
|
$-0.24M |
|
$-0.24M |
|
$-0.24M |
|
$-0.16M |
|
$-0.13M |
|
66.19M |
|
66.19M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.00M |
|
-- |
|
-- |
|
$0.00M |
|
$0.37M |
|
-- |
|
-- |
|
$0.37M |
|
$-0.36M |
|
$-0.36M |
|
$-0.36M |
|
70.47M |
|
| Cash Flow Statement Financials | |
$-0.06M |
|
-- |
|
$0.03M |
|
$0.04M |
|
$0.00M |
|
$-0.03M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-- |
|
-0.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
66.19% |
|
66.19% |
|
-5716.30% |
|
66.19% |
|
$-0.01 |
|
$-0.00 |
|
$-0.00 |
|